Method for Predicting Cancer Risk Value Based on Multi-Omics and Multidimensional Plasma Features and Artificial Intelligence
Copyright © Targeted News Service 2026
2026-11-17
ALEXANDRIA, Virginia, Nov. 17 -- SEEKIN INC., San Diego, California has been assigned a patent (No. US 12799537 B2, initially filed Aug. 12, 2021) developed by six inventors Shiyong Li, Shenzhen, China; Mao Mao, Shenzhen, China; Guolin Zhong, Shenzhen, China; Yan Chen, Huizhou, China; Wei Wu, Shenzhen, China; and Yumin Feng, Shenzhen, China, for "Method for predicting cancer risk value based on multi-omics and multidimensional plasma features and artificial intelligence." . . .
